AIMS: Although multiple recent studies have confirmed an association between chronic proton-pump inhibitor (PPI) use and hypomagnesaemia, the physiologic explanation for this association remains uncertain. To address this, we investigated the association of PPI use with urinary magnesium excretion. METHODS: We measured 24-hour urine magnesium excretion in collections performed for nephrolithiasis evaluation in 278 consecutive ambulatory patients and determined PPI use from contemporaneous medical records. RESULTS: There were 50 (18%) PPI users at the time of urine collection. The mean daily urinary magnesium was 84.6 ± 42.8 mg in PPI users, compared with 101.2 ± 41.1 mg in non-PPI users (P = 0.01). In adjusted analyses, PPI use was associated with 10.54 ± 5.30 mg/day lower daily urinary magnesium excretion (P = 0.05). Diuretic use did not significantly modify the effect of PPI on urinary magnesium. As a control, PPI use was not associated with other urinary indicators of nutritional intake. CONCLUSIONS: Our findings suggest that PPI use is associated with lower 24-hour urine magnesium excretion. Whether this reflects decreased intestinal uptake due to PPI exposure, or residual confounding due to decreased magnesium intake, requires further study.
AIMS: Although multiple recent studies have confirmed an association between chronic proton-pump inhibitor (PPI) use and hypomagnesaemia, the physiologic explanation for this association remains uncertain. To address this, we investigated the association of PPI use with urinary magnesium excretion. METHODS: We measured 24-hour urine magnesium excretion in collections performed for nephrolithiasis evaluation in 278 consecutive ambulatory patients and determined PPI use from contemporaneous medical records. RESULTS: There were 50 (18%) PPI users at the time of urine collection. The mean daily urinary magnesium was 84.6 ± 42.8 mg in PPI users, compared with 101.2 ± 41.1 mg in non-PPI users (P = 0.01). In adjusted analyses, PPI use was associated with 10.54 ± 5.30 mg/day lower daily urinary magnesium excretion (P = 0.05). Diuretic use did not significantly modify the effect of PPI on urinary magnesium. As a control, PPI use was not associated with other urinary indicators of nutritional intake. CONCLUSIONS: Our findings suggest that PPI use is associated with lower 24-hour urine magnesium excretion. Whether this reflects decreased intestinal uptake due to PPI exposure, or residual confounding due to decreased magnesium intake, requires further study.
Authors: Michael D Howell; Victor Novack; Philip Grgurich; Diane Soulliard; Lena Novack; Michael Pencina; Daniel Talmor Journal: Arch Intern Med Date: 2010-05-10
Authors: Ewout J Hoorn; Joost van der Hoek; Rob A de Man; Ernst J Kuipers; Clemens Bolwerk; Robert Zietse Journal: Am J Kidney Dis Date: 2010-02-26 Impact factor: 8.860
Authors: Ioannis Koulouridis; Mansour Alfayez; Hocine Tighiouart; Nicolaos E Madias; David M Kent; Jessica K Paulus; Bertrand L Jaber Journal: Am J Kidney Dis Date: 2013-05-10 Impact factor: 8.860
Authors: Kenneth P Chen; Joon Lee; Roger G Mark; Mengling Feng; Leo A Celi; Brian E Malley; John Danziger Journal: J Clin Pharmacol Date: 2015-03-16 Impact factor: 3.126
Authors: Wilson Sui; Nicole L Miller; Edward R Gould; Kevin C Zhang; Tatsuki Koyama; Ryan S Hsi Journal: Urolithiasis Date: 2022-05-02 Impact factor: 2.861
Authors: Parth M Patel; Alexander M Kandabarow; Eseosa Aiwerioghene; Enrique Blanco-Martinez; Spencer Hart; David J Leehey; Ahmer Farooq; Kristin G Baldea; Thomas M T Turk Journal: Int Urol Nephrol Date: 2020-11-18 Impact factor: 2.370
Authors: Simone Janett; Pietro Camozzi; Gabriëlla G A M Peeters; Sebastiano A G Lava; Giacomo D Simonetti; Barbara Goeggel Simonetti; Mario G Bianchetti; Gregorio P Milani Journal: Gastroenterol Res Pract Date: 2015-05-04 Impact factor: 2.260
Authors: Michael Simonov; Erica A Abel; Melissa Skanderson; Amir Masoud; Ronald G Hauser; Cynthia A Brandt; Francis P Wilson; Loren Laine Journal: Clin Gastroenterol Hepatol Date: 2020-03-06 Impact factor: 11.382